Inactive Instrument
Sector Taro Pharmaceutical Industries Ltd. Other OTC
Stocks
IL0010827181
Pharmaceuticals
|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 07-01 | FDA Grants Tentative Approval for ANDA 212581 Azelaic Acid Topical Foam | CI |
| 25/06/24 | Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.01% | +1.24% | +0.85% | -3.68% | +10.23% | +63.06% | +120.55% | +414.25% | +1,385.62% | 1,056B | |
| -1.61% | -0.60% | -0.18% | +3.50% | +29.29% | +47.32% | +71.79% | +63.13% | +128.17% | 645B | |
| -1.12% | -0.72% | +3.06% | +3.53% | +15.23% | +17.98% | +76.63% | +141.91% | +319.12% | 465B | |
| -1.72% | -4.06% | -2.62% | +3.10% | +6.43% | +36.39% | +39.47% | +3.33% | +44.46% | 335B | |
| -0.40% | +3.83% | -2.28% | -4.18% | +10.33% | +22.08% | +28.82% | +56.57% | +56.53% | 275B | |
| -0.51% | -1.93% | +3.83% | -13.08% | -9.88% | +12.09% | +11.94% | +40.70% | +147.27% | 255B | |
| +1.32% | +3.27% | -2.03% | +17.50% | +29.43% | +54.63% | +57.63% | +97.13% | +156.05% | 229B | |
| -0.61% | -0.91% | +3.84% | +19.75% | +23.25% | +34.33% | +101.87% | +113.25% | +94.30% | 188B | |
| -0.24% | -2.76% | -14.84% | -20.09% | -22.63% | -28.41% | -60.92% | -17.92% | +79.75% | 169B | |
| 0.00% | +2.83% | +2.72% | +17.85% | +15.34% | +20.42% | -13.42% | -34.02% | -13.81% | 164B | |
| -0.18% | +2.28% | -2.76% | +5.42% | +16.18% | +33.24% | +51.47% | +189.06% | +519.68% | 134B | |
| -1.60% | +0.98% | -5.59% | +7.34% | +16.54% | +42.38% | +8.30% | +3.70% | +16.69% | 128B | |
| -0.22% | -2.62% | +0.13% | -6.24% | +1.73% | +22.27% | +24.40% | +5.68% | -9.88% | 98.21B | |
| -0.74% | -3.93% | -7.48% | -5.34% | -13.60% | -8.70% | -29.57% | -14.62% | +5.06% | 97.03B | |
| +1.95% | -6.60% | -10.15% | -17.56% | -24.65% | -3.68% | +36.99% | +51.38% | +412.60% | 63.61B | |
| +0.94% | -1.60% | +0.45% | +12.34% | +19.77% | +34.21% | +26.55% | +56.56% | +20.07% | 58.12B | |
| -3.78% | -1.35% | +0.43% | +6.19% | +32.07% | +76.37% | +7.55% | +3.08% | -44.64% | 54.41B | |
| +2.39% | +0.73% | +7.59% | +31.21% | +39.15% | +98.95% | +291.06% | +305.40% | -22.03% | 46.39B | |
| +2.59% | -0.22% | -3.59% | -13.81% | -23.42% | -34.08% | +1.51% | -8.61% | +180.13% | 44.75B | |
| Average | +0.12% | -0.80% | -1.51% | +2.30% | +8.99% | +28.47% | +44.88% | +77.37% | +182.90% | 237.07B | |
| Weighted average by Cap. | -0.07% | +0.08% | -0.52% | +1.14% | +12.05% | +36.52% | +61.85% | +144.63% | +428.45% |
- Stock Market
- Stocks
- TARO Stock
- Stock
- Sector Taro Pharmaceutical Industries Ltd.
Select your edition
All financial news and data tailored to specific country editions
